July 2015

Why government needs more randomized controlled trials: Refuting the myths

The Laura and John Arnold Foundation (LJAF) today released a policy brief focused on the value and benefits of randomized controlled trials (RCTs). Such trials are widely recognized as the gold standard in scientific research. However, some critics have claimed that they are often expensive, time-consuming, unethical, or not worth the trouble. These objections are almost … Read More

Rising U.S. drug prices are focus of research grant

Read More

Series of reports will analyze cost, benefit of pricey drugs

Read More

Arnold Foundation puts $5 million into research on rising drug prices

Read More

ICER launches new drug assessment program with $5.2 million award from the Laura and John Arnold Foundation

Houston, Texas, and Boston, Mass.—With drug prices for cancer and many other conditions soaring to new highs amid questions about their true value to patients, the Institute for Clinical and Economic Review (ICER) today launched a program to transform the way new drugs are evaluated and priced in the United States. Funded by a $5.2 … Read More